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Hypovolaemic Shock: assessment, pathophysiology and nursing care. 
Abstract 
Hypovolaemia leads to a number of key physiological responses which require systematic 
assessment and interpretation. This article focuses on a case study involving a patient with 
Parkinson’s disease who became hypovolaemic following a fall at home, to illustrate the 
impact of hypovolaemia and current recommendations regarding fluid resuscitation. ABCDE 
assessment is considered as well as arterial blood gas analysis and interpretation is 
explained in light of the patient scenario.  
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Key Points  
 Hypovolaemia can lead to a number of systemic responses 
 Careful and systematic interpretation of arterial blood gases is an important element 
to assessing the impact of hypovolaemia 
 Early, balanced fluid resuscitation is an essential aspect of patient management and 
can prevent patient deterioration 
 
 
  
Hypovolaemic Shock: assessment, pathophysiology and nursing care 
Hypovolaemic shock refers to the serious clinical condition of acute circulatory failure. It is 
characterised by loss of 15% or more of intravascular circulating volume, leading to 
inadequate tissue perfusion and potential tissue necrosis (Zelman et al, 2011; Porth, 2015). 
There are a number of possible causes of hypovolaemia including severe external 
haemorrhaging or internal fluid shifts as a result from dehydration (Garretson and Malberti, 
2007). This article focuses on a case study, Clive (pseudonym as per NMC requirements 
(NMC, 2015), who was admitted to critical care from the emergency department (ED). He 
has Parkinson’s disease and fell at home. His case study will illustrate the effects of 
hypovoalemia and to offer a rationale for the assessment findings, underlying 
pathophysiology and associated patient care. It will also consider why he may have fallen 
and how his Parkinson’s disease can be effectively managed in a critical care situation.  
 
Case study 
Clive was an 80 year old gentleman who was admitted to critical care following a fall at 
home three days previously. As he was unable to get off the floor following his fall, he was 
dehydrated and confused, with the risk of developing acute kidney injury. He has 
Parkinson’s disease (PD) and he lives on his own although his family live nearby and he is 
normally fully independent. In the emergency department, as he had not had his anti- 
Parkinsons medication for 3 days, he was showing signs of associated motor impairment 
(stiffness and rigidity) which was noted on his secondary survey. He therefore needed 
dopamine agonist medication to improve his motor function. As his swallow was not 
impaired, his usual Parkinson’s medication was administered which comprised of Co- 
careldopa 100/25 mg x 2 orally.  
Assessment  
On admission, Clive was assessed using the ABCDE (airway, breathing, circulation, disability, 
and environment) framework developed by the Resuscitation Council (2005).  This allowed 
for a systematic approach to Clive’s assessment with life threatening changes identified in a 
prioritised manner (Jevon, 2010). This allowed for proactive interventions and treatments to 
avoid further deterioration.  THE ABCDE approach is a widely accepted process to assessing 
patients who are either already critically ill, or those who face the potential risk of 
deteriorating. Studies have shown that this framework is particularly useful in an emergency 
setting and not only serves to provide life-saving care and treatment, but that it also 
improves the performance of the multi-disciplinary team involved in patients’ care (Thim et 
al, 2012). 
Airway: 
On assessment Clive’s airway did not appear to be compromised as he was able to respond 
verbally to questions. However as he appeared exhausted and was hypotensive, ongoing 
airway assessment was required in case his level of consciousness deteriorated further.  
Breathing 
Assessment of Clive’s respiratory function involved counting his respiratory rate, assessing 
the depth of inspiration and observing for symmetrical chest expansion (Jevon, 2010).  On 
assessment, the following was found: 
• Respiration rate:  26 breaths/minute. 
• He was dyspnoeic. 
• Shallow breaths and use of accessory muscles. 
• No signs of central cyanosis 
• Symmetrical chest movement with normal rhythm. 
• SpO2:  95% on 60% oxygen via a venturi mask 
Clive was tachypnoeic with a respiratory rate of 26 breaths per minute. His shallow 
breathing and use of accessory muscles suggested an increased work of breathing. Clive was 
self-ventilating on 60% oxygen with a peripheral oxygen saturation (SpO2) of 95%. Although 
Clive’s recorded SpO2 was within national guideline targets (SpO2 94-98%) and no signs of 
central cyanosis were present, clinical judgement proposes a SpO2 of 95% is low for 
someone receiving supplemental 60% oxygen therapy (British Thoracic Society, 2008).  
Circulation 
Assessment of Clive’s circulatory condition provided further detail regarding the cause of his 
condition. Assessment of circulation involves assessing pulses, blood pressure and tissue/ 
organ perfusion. Clive’s assessment showed: 
 Heart rate    130 BPM 
 Blood pressure   100/40 mmHg  
 Mean arterial pressure  60 mmHg 
 Central venous pressure  2 mmHg 
 Core temp    36.5 ºC 
 His limbs felt cool and his capillary refill was 3 seconds 
 He had a catheter inserted in the emergency department and there was 20 ml in the 
bag  
Results from the assessment revealed that Clive was tachycardic, hypotensive with a 
decreased mean arterial pressure (MAP) and a decreased central venous pressure (CVP), 
suggesting he was in shock. Clive’s cool peripheries, prolonged capillary refill time and 
oliguria suggested that he had decreased tissue perfusion (Clarke and Ketchell, 2011). With 
a temperature of 36.5 °C, Clive was apyrexial.  
As he was showing signs of shock, cardiac output monitoring was commenced on admission 
to the critical care unit and the following readings were obtained: 
 
 Systemic vascular resistance index   2400 dynes · sec/cm5/m2 
 Cardiac index      1.3 l/min/ m2 
 Stroke volume      30 ml 
The results from Clive’s invasive cardiac output monitoring revealed an increased systemic 
vascular resistance index (SVRI) (normal values: 1,360- 2,200 dynes · sec/cm5/m2) and a 
decreased cardiac index (CI) (normal value: 2.6–4.2 L/min/m2) and stroke volume (SV) 
(normal value 60- 80 ml).  A reduced SVRI is often presented as a classic sign of sepsis, in 
response to widespread vasodilation which would contribute to warm, flushed peripheries. 
However, Clive’s raised SVRI suggested he was vasoconstricted and a reduced CI and SV 
signified a low blood volume as indicated also by the reduced CVP. Therefore, he did not 
appear to have developed sepsis or systemic inflammatory response syndrome (SIRS) 
(Aitken et al, 2015). In view of the background to his admission and that there are no clinical 
signs of haemorrhage or reported history of a cardiac event, the findings indicated that Clive 
was  experiencing hypovolaemic shock as opposed to haemorrhagic or cardiogenic shock 
(Clarke and Ketchell, 2011).  
The oliguria suggested he had developed acute kidney injury. This could be due to fluid 
responsive renal failure which can occur when there is reduced renal perfusion. However, in 
consideration of the prolonged period of time Clive spent lying stationary, intra-renal failure 
may have developed due to rhabdomyolysis.    
 
Disability 
The disability stage of ABCDE focuses on assessment of any neurological alteration and 
possible causes. Assessment of Clive’s neurological state identified that he was: 
 Rousable to speech on the AVPU scale.  
 He was confused to time, place and person. 
 He had regained his motor function following administration of his dopamine 
agonist. 
 Blood sugar levels: 3 mmol/l. 
These results demonstrated signs of neurological dysfunction which was of concern as Clive 
fell at home and could possibly have sustained a head injury. Therefore, he was assessed 
using the Glasgow coma score (GCS) which showed: eyes: open to speech (3), verbal 
response: confused (4); motor response: obeying commands (6). His pupils were equal in 
size (3 mm) and reacting briskly. He had a mild weakness in each limb on assessment of limb 
power. To exclude any cerebral pathology, such as a subdural haemotoma, a computerised 
tomography (CT) scan was performed which showed no sign of cerebral haemorrhage or 
raised intracranial pressure.  
 
Exposure 
The last part of ABCDE assessment is focused on assessing for any other signs of injury that 
have not be noted. Clive’s assessment identified: 
 An area of redness on his right hip where he had been lying on the floor.  
As part of Clive’s on-going assessment, an arterial blood gas (ABG) was taken so that vital 
information regarding his internal respiratory and metabolic status was obtained. This will 
demonstrate Clive’s ability to maintain homeostasis and help explain his respiratory 
assessment findings (Larkin and Zimmanck, 2015).  
 
Arterial blood gases (ABGs) 
For the critically ill patient timely interpretation of appropriate investigations will lead to 
essential treatment. Arterial blood gases (ABGs) offer useful information about gas 
exchange, the metabolic status of the patient and the body’s ability to maintain a normal 
acid: base balance. Normal ranges for each parameter are:  
 
 
 
 
 
ABGs reveal the pH (normal range 7.35-7.45) which indicates the concentration of hydrogen 
ions (H+). Changes in pH can be due to respiratory or metabolic causes. If the alteration in 
pH is due to respiratory causes, then this will be reflected within the partial pressure of 
carbon dioxide (pCO2) (normal range 4.6-6.0 kPa), with an increase in pCO2 leading to an 
acidosis (and a decrease leading to an alkalosis).  The partial pressure of oxygen (pO2) 
(normal range 10-13.3 kPa) is also obtained and therefore any hypoxaemia can be identified 
but the pO2 does not alter the pH.  The measurements of bicarbonate ions (HCO- 3) (normal 
range 22-26 mmol/L) and base excess (normal range -2 to +2) identify whether any change 
in pH is due to metabolic causes; a decrease in HCO- 3 and base excess are associated with a 
metabolic acidosis whereas an increase in these values is suggestive of a metabolic alkalosis. 
Careful and systematic interpretation of ABGs therefore assists in differentiating between 
metabolic and respiratory causes of changes in pH and also allow for identification of 
pH   7.35- 7.45 
pO2   10- 13.3 kPa 
pCO2   4.6- 6.0 kPa 
HCO-3   22-26 mmol/l 
Base Excess  -2- +2 
whether any compensation is happening. Through assessment of these measurements, 
suitable management can be identified (McLeod, 2016). 
 
pH control  
As a by-product of many metabolic processes, H+ ions are continuously generated. A high 
concentration of H+ constitutes for an acidic environment equalling to a low pH, which can 
have detrimental effects on cellular activity.  In health, the normal range of pH is maintained 
by the balancing of acid and base via three mechanisms: buffering, the respiratory response 
and the renal response (McLeod, 2016): 
1)  Buffers are able to rapidly and reversibly combine with H+, neutralising its effect 
thus maintaining a relatively constant pH. Bicarbonate, protein, phosphate and 
haemoglobin form the key buffers and the availability of buffers to combine with 
hydrogen is reflected within the base excess reading on the ABG. A negative reading 
implies that buffers are depleted whereas a positive reading suggests that there is 
available buffer. (Porth, 2015) 
2) The respiratory response involves HCO- 3 and H
+ combining to form carbonic acid 
(H2CO3). This molecule can easily dissociate into water (H2O) and carbon dioxide 
(CO2), both of which can be expelled via the lungs: 
HCO- 3 + H           H2CO3                 H2O + CO2 
 Increased levels of H+ will additionally be detected by chemoreceptors in the brain 
stem and carotid and aortic arteries. Chemoreceptors signal the respiratory centre in 
the medulla oblongata which initiates an increase in pulmonary ventilation, aiming 
to breathe out hydrogen in the form of carbon dioxide (McLeod, 2016).  
3) The renal response involves the renal tubular cells forming HCO- 3 from the 
combination of CO2 and H2O within the tubular cells. The HCO
- 
3 which is formed 
when H2CO3 dissociates into HCO
- 
3 and H
+, passes into the blood whereas the H+ is 
secreted into the filtrate within the renal tubules. The movement of the HCO- 3 into 
the blood stream helps to correct the pH.  
Interpretation of ABGs 
Clive’s arterial blood gases were:  
 
  
 
 
 
 
In comparison to the normal values of ABGs, Clive’s pH, pO2, pCO2, HCO
- 
3 and base excess 
are all reduced. This indicates that he had a primary metabolic acidosis (low pH, low HCO- 3 
and reduced base excess) with partial respiratory compensation (low pCO2). 
Clive’s low pH of 7.33 identified that he was acidotic. In order to establish the primary cause 
of Clive’s acidosis, the pCO2, HCO
- 
3 and base excess levels were assessed. As both the HCO
- 
3 
and base excess were low, there was a metabolic acidosis present as opposed to a 
respiratory acidosis which would have been caused by an increased pCO2.  
Conversely, Clive’s pCO2 was low. The Henderson-Hasselbalch equation describes the 
normal relationship between HCO- 3 and pCO2 as inverse, however Clive’s readings showed 
that both variables are low (McLeod, 2016). In a compensatory response to the high levels 
of H+, Clive’s respiratory centre was stimulated by the increased hydrogen within his blood. 
This led to an increase in respiratory rate and therefore the tachypnoea which was 
observed, was caused by the respiratory response as previously outlined. As the pH of 
Clive’s arterial blood had not fully returned to a normal range of 7.35- 7.45, he was in a state 
of metabolic acidosis with partial respiratory compensation (McLeod, 2016).  
Clive’s pO2 was low and therefore he had a hypoxaemia which was suggested also by the 
low SpO2.  Additional tests revealed an elevated level of lactate of 2.4 mmol/L, normal levels 
are below 2mmol/L. Lactate is a by-product of anaerobic cellular respiration, which occurs 
when there is inadequate oxygen delivery or perfusion to the cells (Bench and Brown, 2011). 
This suggested that Clive’s acidotic state was due to possible shock or sepsis (McLeod, 
 pH   7.33 
 pO2   9 kPa 
 pCO2   3.8 kPa 
 HCO- 3   18 mmol/l 
 BE   -5  
 Lactate  2.4 mmol/l 
2016). To successfully treat a metabolic acidosis the underlying cause must be identified and 
treated.  
 
Underlying physiology/ pathophysiology 
On assessment, Clive was showing signs of a compensatory response to the hypovolaemia 
shock. 
 
Shock Mechanisms 
Starling’s law of the heart states that there is a direct relationship between the preload (the 
volume of blood within the ventricle stretching the myocardium fibres) and contractility (the 
forcefulness of the myocardial contraction). This will affect the stroke volume which is the 
volume of blood ejected by the ventricle in one contraction and ultimately the cardiac 
output which is HR x SV and equates to the amount of blood ejected in one minute (Aitken 
et al, 2015). A depleted circulating volume reduced Clive’s preload, resulting in a decreased 
SV and therefore a low CI, which is his cardiac output in relation to his body mass index. This 
was reflected within his low systolic blood pressure (BP) (Jevon and Ewens, 2012). Although 
deemed sufficient for some patients, a systolic BP of 100 mmHg is not expected for an 80 
year old man. However, in comparison to his low CI, Clive’s BP appeared to be sufficient. 
This suggested that Clive was in a compensated stage of hypovolaemic shock (Aitken et al, 
2015). 
 
Sympathetic Nervous System response  
In response to a drop in BP, the sympathetic nervous system initiates a compensatory 
response, aiming to maintain a sufficient CI. Baroreceptors in the aortic arch and carotid 
sinus detect a decreased circulating volume and instigate a message to the cardiac 
vasomotor centre, located in the medulla oblongata (Clarke and Ketchell, 2011). Here, 
stimulation of sympathetic nerves initiates the release of catecholamines (epinephrine and 
norepinephrine) from the adrenal glands, resulting in vasoconstriction and increased 
myocardial contractility. This response attempts to maintain organ perfusion by improving 
cardiac output (Aitken et al, 2015). Therefore, BP= CO x SVR. Clive’s tachycardia and signs of 
poor peripheral perfusion, which contributed to the development of metabolic acidosis, 
reiterate the physiological process of hypovolaemic shock.    
 
Renin angiotensin aldosterone system (RAAS) 
As an additional compensatory measure, the kidneys stimulate the homeostatic mechanism 
which is the renin- angiotensin- aldosterone system (RAAS). A decreased renal arterial 
pressure, caused by low blood volume, leads to a reduced filtrate flow within the renal 
nephron which is detected by the juxtaglomerular apparatus and renin is released. Renin 
modifies circulating angiotensinogen into angiotensin I. Once in the lungs and in the 
presence of angiotensin converting enzyme, angiotensin I is converted into the active 
angiotensin II, which causes arterial vasoconstriction. This increases systemic blood 
pressure, and therefore glomerular filtration pressure (Porth, 2015).  
 
Simultaneously, circulating angiotensin II stimulates the secretion of aldosterone, from the 
adrenal cortex. Aldosterone promotes the reabsorption of sodium from the renal tubules, 
thus increasing the intracapillary oncotic pressure causing retention of water. Additionally, 
the increased osmolality of the blood stimulates the secretion of anti-diuretic hormone 
(ADH) from the posterior pituitary gland. ADH also promotes water reabsorption by 
increasing the permeability of the renal tubules (Jevon and Ewens, 2012). Both mechanisms 
aim to improve circulatory function by increasing circulating volume however, over a period 
of time these mechanisms reduced Clive’s glomerular filtration rate resulting in oliguria. 
Based on Clive’s weight his normal urine output should be 30mls per hour, but only 20mls 
was reported. This indicated that Clive was developing acute kidney injury.  (Creed and 
Spiers, 2010).  
 
Cerebral perfusion 
Clive was showing signs of confusion on admission, although he was responsive to verbal 
stimulation. This suggested that he had a reduced level of consciousness which was likely to 
be due to a reduction in cerebral perfusion. The brain requires a cerebral blood flow of 
50ml/100g/min to meet the metabolic requirements of neurones, and utilises around 3-5 ml 
O2 /min/100g and 5 mg glucose/min/100g. Clive had a low blood pressure and was 
hypoglycaemic- neurones cannot store glucose and have limited ability to undergo 
anaerobic respiration as there no local supply of glycogen to convert into glucose. Therefore 
neurones rely on a continuous supply of both oxygen and glucose; should the supply be 
inadequate, then alterations in level of consciousness is observed as in Clive’s situation.  
 
Rhabdomyolysis  
 
Clive’s profile along with the noted erythema on his right hip indicated that he may have 
been immobile for an extensive period of time: this suggested the possibility of the 
development of rhabdomyolysis.  Alongside Clive’s underlying pathophysiology, 
rhabdomyolysis can place his metabolic state and renal function at further risk.  
 
Prolonged compression on an isolated area can result in localised ischaemia, due to 
impaired perfusion to skeletal muscles (Baaijens et al. 2015). The ischaemic environment 
leads to anaerobic cellular respiration, resulting in depleted levels of ATP within myocytes 
and production of lactate; constituting for further metabolic acidosis. Low levels of ATP 
hinder the action of calcium ATPase pumps leading to increased levels of calcium within the 
sarcoplasm, which initiates myofibril contraction. A constant state of contraction exhausts 
all energy resources resulting in lysis of the myocyte and over time skeletal muscle necrosis 
(Williams and Thorpe, 2014).   
 
Disintegration of the myocyte results in a release of the intracellular contents, including 
numerous ions and the protein myoglobin into circulation. Once in circulation myoglobin is 
rapidly filtered by the glomerulus, leading to myoglobinuria manifesting as dark red/brown 
coloured urine (Porth, 2015). Within acidic environments, as found in the renal tubules 
myoglobin is nephrotoxic causing damage and obstruction (Williams and Thorpe, 2014). For 
Clive this additional insult would further exacerbate the development of acute kidney injury. 
Alongside clinical manifestations such as localised erythema and muscle weakness further 
laboratory investigation can provide a definitive diagnosis of rhabdomyolysis for Clive. High 
elevated levels of creatine kinase (> ten times normal) indicates a breakdown of myocytes 
and is used as a primary indicator for the condition. Metabolic acidosis and an increased 
level of serum electrolytes, such as potassium further support the diagnosis (Aitken et al, 
2015) 
 Patient Management 
 
Hypovolaemia 
Treatment of hypovolaemic shock focuses on regaining adequate tissue perfusion via 
restoration of fluid volume and BP. Consequently, fluid resuscitation will improve oxygen 
delivery to cells, enabling aerobic respiration, which in-turn will help restore the acid-base 
disparity (Garretson and Malberti, 2007). Guidelines proposed by the National Institute for 
Health Care and Excellence (NICE) (2013) recommend a fluid challenge of a 500ml crystalloid 
bolus, over 15 minutes for any patient suspected of hypovolaemia. Based on Clive’s 
physiological profile, his age was suggestive of potential reduced cardiovascular function. 
Administration of too much fluid, too quickly increases the risk of iatrogenic chronic heart 
failure, as the heart is unable to cope with the sudden rise in blood volume (Creed and 
Spires, 2010). Therefore, Clive was prescribed boluses of 250ml crystalloid to assess for fluid 
responsiveness: boluses should be given until there is no further response and at that point, 
fluid resuscitation should not continue as preload should be adequate (Aitken et al, 2015) 
Fluid resuscitation using crystalloids provides a transient intravascular expansion and further 
replaces accompanying fluid loss in interstitial and intracellular spaces. Hypertonic colloids 
are normally only indicated to replace large volumes of fluid loss, or to restore low 
haemoglobin levels, due to their higher cost and associated risks such as alteration in 
clotting (Garretson and Malberti, 2007). The CRISTAL trial (Annane et al, 2013) did not show 
any significant different in 28 day mortality rates in hypovolaemic patients in intensive care 
who received either crystalloids or colloids.  
Sequential monitoring of vital signs and cardiac output are imperative when managing a 
patient receiving a fluid challenge. Fluid boluses should be repeated until a rise of 3mmHg 
or more is seen in the CVP, 5 to 10 minutes after the bolus has been fully administered 
(Aitken et al, 2015). The CVP indicates the amount of blood returning to the heart and thus 
cardiac output, therefore it is a useful guide when observing the effect of a fluid challenge 
(Porth, 2015). However, CVP readings should not be used independently, as CVP can also be 
sensitive to vasoconstriction. Vincent and Weil (2006) recommended using the CVP as a 
safety guide to prevent hypervolaemia, using quantitative clinical goals such as, blood 
pressure, heart rate and MAP to help observe an increased peripheral perfusion.  
For safe and effective administration of IV fluids NICE (2013) recommend using the 
principles of the five R’s: Resuscitation, Routine maintenance, Replacement, Redistribution 
and Reassessment. Once Clive appears haemodynamically stable, after resuscitation, 
treatment should focus on replacement of any electrolyte deficits (Sherratt, 2014). 
Therefore, a maintenance plan including 500ml Hartmanns solution and 500ml 5% dextrose 
was prescribed for Clive. The British consensus guidelines on intravenous fluid therapy for 
adult surgical patients (Powell-Tuck et al. 2011) endorse Hartmanns solution over 0.9% 
saline as this can contribute to hyperchloraemic acidosis, particularly in the elderly. The 
isotonic nature of crystalloids such as Hartmanns solution, result in distribution within the 
interstitial space, ensuring adequate replacement of lost electrolytes, such as potassium and 
sodium (Dougherty and Lamb, 2008). To help distribute fluid evenly amongst the body’s 
compartments, the British National Formulary (British Medical Association and Royal 
Pharmaceutical Society, 2016), advise for an equal infusion of 500ml 5% dextrose, to aid 
intracellular hydration. The metabolism of glucose, within dextrose, lowers the osmolarity 
of extracellular fluid creating a hypotonic environment, causing a net movement of fluid into 
the cells moving down its pressure gradient (Porth, 2015).  Care though needs to be taken if 
there is any suggestion of altered intracerebral pressure (ICP) as dextrose containing 
solutions can increase ICP. As Clive’s CT scan did not show any signs of raised ICP, it was safe 
to administer 5% dextrose. 
 
Rhabdomyolysis 
 If rhabdomyolysis is confirmed, treatment is aimed at preserving renal function and 
reversing metabolic abnormalities. Volume replacement using 0.9% sodium chloride is 
supported, at a rate of 1.5 l/h to maintain a urine output of 200- 300 ml/ hr (Zut et al, 2014). 
This allows for an increase in glomerular filtration rate and therefore removal, or washing 
out, of myoglobin. This should continue until the serum creatinine kinase has declined to 
1000 IU/l or lower- careful monitoring is required as this volume of fluid could precipitate 
fluid overload and therefore pulmonary oedema.  
In Clive’s situation, although he was at risk of developing rhabdomyolysis, his creatinine 
kinase was not more than 10 times normal, so he was not diagnosed as having developed 
this.  
Orthostatic hypotension 
It was important when Clive had been stabilised to establish why he fell at home. Woodford 
and Walker (2005) report that 14% of patients with PD who are admitted to hospital as an 
emergency admission is due to them falling. Other reasons for admission are infective 
diseases (21%), orthostatic hypotension (OH) (4%) and hypovolaemia (2%). Infective 
disorders, such as urinary tract infections, can lead to falls as can OH, and hypovolaemia can 
result from falling as in Clive’s situation. On discussion with Clive and his family, it became 
apparent that he had been having signs of OH shortly before falling. OH is one of the main 
non- motor features of PD. It is thought to occur because of degeneration of the autonomic 
system as the disease progresses (Velseboer et al, 2011), leading to ineffective 
vasoconstriction and excessive pooling of blood in the venous system. This then leads to 
cerebral hypoperfusion and can lead to dizziness and fainting: Clive had been experiencing 
dizziness on standing up.  
Drugs are known to bring about and aggravate symptoms of OH (Perez- Lloret et al, 2012). 
Levodopa and dopamine agonists can lead to and worsen OH. Other drugs such as 
antipsychotics, antidepressants, diuretics and antihypertensives can also worsen OH. Perez- 
Lloret et al (2012) found that age, polypharmacy and use of amantadine and diuretics were 
the main factors related to OH. It was therefore important that Clive’s drug therapy was 
reviewed to reduce the OH he was experiencing.  
 
Management of his PD in critical care 
When Clive was admitted he was able to take his dopamine agonist orally which relieved the 
PD symptoms he was displaying in the ED. If he had been unable to take these orally, it 
would have been essential to administer dopamine agonists via an alternative route. 
Patches can be used to administer the dopamine agonist Rotigotine.  It is important to 
correctly convert the oral dosage into the equivalent patch dose which may require 
consultation with the pharmacist or Parkinson’s disease nurse specialist (PDNS). Madopar 
dispersible can be given via a nasogastric tube. Additionally, Apomorphine can be 
administered subcutaneously, however the cardiovascular effects of this drug would need 
to be observed for: it can cause hypotension and bradycardia both of which would be 
problematic in Clive’s shock status. If this was given, Domperidone should be administered 
prior to the Apomorphine as Apomorphine can lead to nausea and vomiting.  
Nursing considerations 
Amongst the machines, noises and continuous observations it can be easy for nurses, in the 
critical care environment, to lose sight of the patient in the centre and the impact the 
experience has on their psychological wellbeing. Ramsay et al. (2014) highlights the 
importance effective rehabilitation can have on improving the patients quality of life, post 
critical care admission. A number of physiological and psychological complications are 
experienced following discharge from critical care, including a reduced appetite, depression 
and weakness. Experience of critical illness can precipitate feelings akin to post traumatic 
stress disorder (PTDS). Jackson et al (2007) found that reported PTDS rates in medical 
intensive care varied from 5%- 63% when they reviewed 16 studies. This is largely attributed 
to the critical care environment as well as the use of sedation- Clive do not require sedation 
to facilitate critical care interventions however, it was important to maintain sensory 
balance and avoid stressors.  Nurses within critical care units play an important role in 
humanising the experience for the patient and their family. Woodrow (2011) advocate 
nurses to regularly orientate the patient and balance sensory stimulation by actively 
promoting an ambient, interesting environment to prevent adverse psychological outcomes. 
Committed to reducing associated long-term consequences of critical care, NICE (2009) 
advocate the application of a multidisciplinary rehabilitation care pathway, starting from 
admission. Early comprehensive assessment can also ensure for a smooth supportive 
discharge. For example in Clive’s case, understanding the nature of his fall allowed for 
prompt referral to the necessary professionals, such as occupational therapists, facilitating 
an optimised recovery.  He also required closer follow up by community based PDNS to 
ensure his symptoms were controlled and being managed effectively. Therefore, the PDNS 
team were consulted and involved in his care within the acute setting prior to his discharge 
back to primary care.  
Conclusion 
Having an in-depth understanding of Clive’s pathophysiological response allowed for clear, 
effective treatment and management. Although this level of knowledge is essential when 
providing care in critical care, its speciality should not allow for discrepancies in knowledge 
in other care settings. Nurses outside of critical care areas need to be aware of the 
consequences of shock so that early patient management can be initiated to avoid patient 
deterioration. Early and thorough assessment using an ABCDE process and escalation to 
critical care outreach is important to prevent the complications of a reduced cardiac output, 
whatever the cause. It was also important to establish the underlying cause of why he fell at 
home and therefore further assessment of his Parkinson’s disease and drug management 
was a very important element to avoid a further similar situation and to enable a safe 
discharge back to the community setting.   
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